Eulerpool Terminal
The edge that pays for itself.
Current CASI Pharmaceuticals forecasts and price targets in August 2026
Ø Analyst Price Targets
4.08 USD
+1,866.27 %
Median
4.08 USD
+1,866.27 %
Max
4.20 USD
Min
4.04 USD
Last Price
0.21 USD
Buy
6
Hold
1
Sell
0
The average target price for CASI Pharmaceuticals is 4.08 USD. (+1,866.27 % above the current price)
The median price target of CASI Pharmaceuticals is 4.08 USD.
Stock analysts from many renowned investment banks are closely examining the CASI Pharmaceuticals stock. They conclude their professional CASI Pharmaceuticals stock analyses with a clear recommendation for the CASI Pharmaceuticals stock. The forecasts and price targets of professional analysts can be a good indicator of how a stock will perform in the next quarter.
| Buy | Hold | Sell | Ø Analyst Price Targets | |
|---|---|---|---|---|
| 2026-02-01 | 6 | 1 | 0 | 4.08 USD |
| 2026-01-01 | 6 | 1 | 0 | 4.08 USD |
| 2025-12-01 | 6 | 1 | 0 | 4.08 USD |
| 2025-12-01 | 6 | 1 | 0 | 4.08 USD |
| 2025-11-01 | 6 | 1 | 0 | 4.08 USD |
| 2025-11-01 | 6 | 1 | 0 | 4.08 USD |
CASI Pharmaceuticals Stock Forecast 2026: Revenue & Earnings Estimates
Analysts expect the following revenue and earnings for CASI Pharmaceuticals in the coming fiscal years:
| Fiscal year | Revenue | Net Income | Earnings per share |
|---|---|---|---|
| 2025e | 13.00 M USD | -39.00 M USD | -2.52 USD |
| 2026e | 70.00 M USD | -21.00 M USD | -1.36 USD |
| 2027e | 89.00 M USD | -21.00 M USD | -1.36 USD |